Status:
UNKNOWN
Treatment Response Evaluation in Patients With Non-resectable Colorectal Liver Metastases A Feasibility Study
Lead Sponsor:
Odense University Hospital
Conditions:
Liver Metastasis Colon Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
More than 4200 new cases of colorectal cancer (CRC) are diagnosed each year in Denmark, and 30.000 patients live with the diagnosis. Up to 40% of CRC patients will have synchronous liver metastases (L...
Detailed Description
Clinical study Evaluation of oncological treatment response in patients with non-resectable colorectal liver metastases based on microscopic tissue analyses obtained by a minimal invasive technique. ...
Eligibility Criteria
Inclusion
- Patients with non-resectable liver metastasis based on a MDT evaluation and the consensus guidelines regarding oncological and technical resectability criteria
- Expected survival \> 6 months (with chemotherapy)
- Informed consent
Exclusion
- 1\. Unfit for chemotherapy and/or laparoscopic evaluation 2. History of other malignant diseases 3. Contraindications to general anesthesia or laparoscopic access (e.g. history of massive abdominal adhesions).
Key Trial Info
Start Date :
May 12 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2019
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03444194
Start Date
May 12 2017
End Date
February 1 2019
Last Update
February 23 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nicolaj Markus Stilling
Odense, Danmark, Denmark, 5000